Trial Search Results

Biomarkers for the Detection of Lymphatic Insufficiency

Acquired lymphedema is a disease that causes chronic swelling of the limb(s). It is frequently under-recognized or misdiagnosed. This study is designed to lead to the development of an accurate, noninvasive, blood test to allow testing for lymphedema. This approach is particularly useful to investigate relative responses to treatment interventions.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):

Intervention(s):

  • Procedure: phlebotomy

Eligibility


Inclusion Criteria

For lymphedema participants:

   - clinical diagnosis of lymphedema of at least 6 months' duration

Control participants:

   - no evidence of lymphedema

Exclusion Criteria

For lymphedema participants:

   - active cancer

   - infection

   - bleeding tendency

   - active coronary artery disease

   - congestive heart failure

   - history of stroke or transient ischemic attack (TIA)

   - uncontrolled hypertension

   - renal insufficiency (serum creatinine > 1.1)

   - active inflammatory or autoimmune disease (other than lymphedema)

For control participants:

   - lymph node dissection

   - radiation therapy

   - active inflammatory disease

Ages Eligible for Study

N/A - N/A

Genders Eligible for Study

All

Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Recruiting